Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2009

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Diabetes Mellitus
Interventions
DRUG

Pramlintide

Pramlintide administered pre-meal starting at 60 mcg and titrating up to 120 mcg within 4-6 weeks

Trial Locations (1)

80045

University of Colorado Denver, Aurora

Sponsors
All Listed Sponsors
collaborator

Amylin Pharmaceuticals, LLC.

INDUSTRY

lead

University of Colorado, Denver

OTHER